Literature DB >> 23872500

No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.

Richard D Johnston1, Mary C Stephenson, Hannah Crossland, Sally M Cordon, Elisa Palcidi, Eleanor F Cox, Moira A Taylor, Guruprasad P Aithal, Ian A Macdonald.   

Abstract

BACKGROUND & AIMS: Diets high in fructose have been proposed to contribute to nonalcoholic fatty liver disease. We compared the effects of high-fructose and matched glucose intake on hepatic triacylglycerol (TAG) concentration and other liver parameters.
DESIGN: In a double-blind study, we randomly assigned 32 healthy but centrally overweight men to groups that received either a high-fructose or high-glucose diet (25% energy). These diets were provided during an initial isocaloric period of 2 weeks, followed by a 6-week washout period, and then again during a hypercaloric 2-week period. The primary outcome measure was hepatic level of TAG, with additional assessments of TAG levels in serum and soleus muscle, hepatic levels of adenosine triphosphate, and systemic and hepatic insulin resistance.
RESULTS: During the isocaloric period of the study, both groups had stable body weights and concentrations of TAG in liver, serum, and soleus muscle. The high-fructose diet produced an increase of 22 ± 52 μmol/L in the serum level of uric acid, whereas the high-glucose diet led to a reduction of 23 ± 25 μmol/L (P < .01). The high-fructose diet also produced an increase of 0.8 ± 0.9 in the homeostasis model assessment of insulin resistance, whereas the high-glucose diet produced an increase of only 0.1 ± 0.7 (P = .03). During the hypercaloric period, participants in the high-fructose and high-glucose groups had similar increases in weight (1.0 ± 1.4 vs 0.6 ± 1.0 kg; P = .29) and absolute concentration of TAG in liver (1.70% ± 2.6% vs 2.05% ± 2.9%; P = .73) and serum (0.36 ± 0.75 vs 0.33 ± 0.38 mmol/L; P = .91), and similar results in biochemical assays of liver function. Body weight changes were associated with changes in liver biochemistry and concentration of TAGs.
CONCLUSIONS: In the isocaloric period, overweight men who were on a high-fructose or a high-glucose diet did not develop any significant changes in hepatic concentration of TAGs or serum levels of liver enzymes. However, in the hypercaloric period, both high-fructose and high-glucose diets produced significant increases in these parameters without any significant difference between the 2 groups. This indicates an energy-mediated, rather than a specific macronutrient-mediated, effect. Clinical trials.gov no: NCT01050140.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP; BMI; C-reactive protein; CRP; EGP; HFCS; HOMA-IR; HTGC; IL; Insulin Resistance; MR; MRS; NAFLD; NEFA; Obesity; Pi; Steatosis; TAG; TE; TNF; TR; adenosine triphosphate; body mass index; echo time; endogenous glucose production; hepatic triglyceride content; high-fructose corn syrup; homeostasis model assessment of insulin resistance; inorganic phosphate; interleukin; magnetic resonance; magnetic resonance spectroscopy; nonalcoholic fatty liver disease; nonesterified fatty acid; repetition time; triacylglycerol; tumor necrosis factor

Mesh:

Substances:

Year:  2013        PMID: 23872500     DOI: 10.1053/j.gastro.2013.07.012

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  69 in total

Review 1.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.

Authors:  Thomas Jensen; Manal F Abdelmalek; Shelby Sullivan; Kristen J Nadeau; Melanie Green; Carlos Roncal; Takahiko Nakagawa; Masanari Kuwabara; Yuka Sato; Duk-Hee Kang; Dean R Tolan; Laura G Sanchez-Lozada; Hugo R Rosen; Miguel A Lanaspa; Anna Mae Diehl; Richard J Johnson
Journal:  J Hepatol       Date:  2018-02-02       Impact factor: 25.083

2.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

Review 3.  What is the appropriate upper limit for added sugars consumption?

Authors:  James M Rippe; John L Sievenpiper; Kim-Anne Lê; John S White; Roger Clemens; Theodore J Angelopoulos
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

Review 4.  Fructose Metabolism from a Functional Perspective: Implications for Athletes.

Authors:  Luc Tappy; Robin Rosset
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

Review 5.  Potential link between excess added sugar intake and ectopic fat: a systematic review of randomized controlled trials.

Authors:  Jiantao Ma; Micaela C Karlsen; Mei Chung; Paul F Jacques; Edward Saltzman; Caren E Smith; Caroline S Fox; Nicola M McKeown
Journal:  Nutr Rev       Date:  2015-10-29       Impact factor: 7.110

6.  Effects of chronic sugar consumption on lipid accumulation and autophagy in the skeletal muscle.

Authors:  Daniela De Stefanis; Raffaella Mastrocola; Debora Nigro; Paola Costelli; Manuela Aragno
Journal:  Eur J Nutr       Date:  2015-10-20       Impact factor: 5.614

7.  Acute effect of fructose intake from sugar-sweetened beverages on plasma uric acid: a randomised controlled trial.

Authors:  E L Carran; S J White; A N Reynolds; J J Haszard; B J Venn
Journal:  Eur J Clin Nutr       Date:  2016-06-22       Impact factor: 4.016

Review 8.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

Review 9.  Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field.

Authors:  Miriam B Vos
Journal:  Curr Opin Lipidol       Date:  2014-02       Impact factor: 4.776

10.  Moderate amounts of fructose- or glucose-sweetened beverages do not differentially alter metabolic health in male and female adolescents.

Authors:  Timothy D Heden; Ying Liu; Young-Min Park; Lauryn M Nyhoff; Nathan C Winn; Jill A Kanaley
Journal:  Am J Clin Nutr       Date:  2014-07-16       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.